Drug Shortage Report for APO-BECLOMETHASONE NASAL SPRAY
Report ID | 166442 |
Drug Identification Number | 02238796 |
Brand name | APO-BECLOMETHASONE NASAL SPRAY |
Common or Proper name | BECLOMETHASONE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | BECLOMETHASONE DIPROPIONATE |
Strength(s) | 50MCG |
Dosage form(s) | SUSPENSION |
Route of administration | NASAL NASAL |
Packaging size | 200 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-08-09 |
Estimated end date | 2022-10-07 |
Actual end date | 2022-09-29 |
Shortage status | Resolved |
Updated date | 2022-09-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-09-30 | French | Compare |
v3 | 2022-09-30 | English | Compare |
v2 | 2022-08-11 | French | Compare |
v1 | 2022-08-11 | English | Compare |
Showing 1 to 4 of 4